FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077080091> ?p ?o ?g. }

• W2077080091 endingPage "219" @default.
• W2077080091 startingPage "210" @default.
• W2077080091 abstract "Angiotensin-converting enzyme (ACE) inhibitors have favourable effects on hypertension and diabetic nephropathy, but persistent use may result in incomplete blockade of the renin-angiotensin system. Long-term effects of dual blockade using the ACE inhibitor lisinopril and the long-acting angiotensin II receptor blocker (ARB) telmisartan on blood pressure and albumin excretion rate (AER) were evaluated. Patients with type 2 diabetes mellitus, hypertension (systolic blood pressure [SBP] >or=140 mmHg or diastolic blood pressure [DBP] >or=90 mmHg) and microalbuminuria (AER 30-300 mg/24h) received 20mg of lisinopril or 80 mg of telmisartan once a day for 24 weeks. Patients were then randomised to continuing treatment with the respective monotherapy or with lisinopril plus telmisartan for a further 28 weeks. Significant (P<0.001) declines in SBP (11.1 mmHg versus 10.0 mmHg), DBP (5.6 mmHg versus 5.3 mmHg) and AER (98 mg/24 h versus 80 mg/24 h) were achieved with lisinopril (n=95) or telmisartan (n=97), respectively, after 24 weeks. Subsequent treatment with lisinopril plus telmisartan for 28 weeks resulted in further significant reductions (P<0.001) in SBP, DBP and AER compared with either monotherapy. All treatments were well tolerated. Lisinopril plus telmisartan thus provides superior blood pressure and AER control than either monotherapy. We conclude that use of dual blockade may provide a new approach to prevention of diabetic nephropathy in patients with type 2 diabetes, hypertension and microalbuminuria." @default.
• W2077080091 created "2016-06-24" @default.
• W2077080091 creator A5012374958 @default.
• W2077080091 creator A5045306658 @default.
• W2077080091 creator A5061071318 @default.
• W2077080091 creator A5086580698 @default.
• W2077080091 date "2006-02-01" @default.
• W2077080091 modified "2023-09-26" @default.
• W2077080091 title "Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension" @default.
• W2077080091 cites W17661181 @default.
• W2077080091 cites W1921375678 @default.
• W2077080091 cites W1970400657 @default.
• W2077080091 cites W1984061204 @default.
• W2077080091 cites W1988361518 @default.
• W2077080091 cites W2011019643 @default.
• W2077080091 cites W2018312583 @default.
• W2077080091 cites W2031335602 @default.
• W2077080091 cites W2043314341 @default.
• W2077080091 cites W2045161455 @default.
• W2077080091 cites W2045790461 @default.
• W2077080091 cites W2047770618 @default.
• W2077080091 cites W2056976690 @default.
• W2077080091 cites W2057739896 @default.
• W2077080091 cites W2061173243 @default.
• W2077080091 cites W2067914302 @default.
• W2077080091 cites W2079135428 @default.
• W2077080091 cites W2084343172 @default.
• W2077080091 cites W2093767212 @default.
• W2077080091 cites W2097521410 @default.
• W2077080091 cites W2104158979 @default.
• W2077080091 cites W2116404316 @default.
• W2077080091 cites W2118989562 @default.
• W2077080091 cites W2123936943 @default.
• W2077080091 cites W2137946319 @default.
• W2077080091 cites W2157420413 @default.
• W2077080091 cites W2323072331 @default.
• W2077080091 cites W2326268984 @default.
• W2077080091 cites W2615684303 @default.
• W2077080091 cites W4237134951 @default.
• W2077080091 cites W4249227027 @default.
• W2077080091 cites W4320300920 @default.
• W2077080091 cites W4360753885 @default.
• W2077080091 doi "https://doi.org/10.1016/j.diabres.2005.06.010" @default.
• W2077080091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16112244" @default.
• W2077080091 hasPublicationYear "2006" @default.
• W2077080091 type Work @default.
• W2077080091 sameAs 2077080091 @default.
• W2077080091 citedByCount "68" @default.
• W2077080091 countsByYear W20770800912012 @default.
• W2077080091 countsByYear W20770800912013 @default.
• W2077080091 countsByYear W20770800912014 @default.
• W2077080091 countsByYear W20770800912015 @default.
• W2077080091 countsByYear W20770800912016 @default.
• W2077080091 countsByYear W20770800912017 @default.
• W2077080091 countsByYear W20770800912019 @default.
• W2077080091 countsByYear W20770800912020 @default.
• W2077080091 countsByYear W20770800912021 @default.
• W2077080091 countsByYear W20770800912023 @default.
• W2077080091 crossrefType "journal-article" @default.
• W2077080091 hasAuthorship W2077080091A5012374958 @default.
• W2077080091 hasAuthorship W2077080091A5045306658 @default.
• W2077080091 hasAuthorship W2077080091A5061071318 @default.
• W2077080091 hasAuthorship W2077080091A5086580698 @default.
• W2077080091 hasConcept C104849204 @default.
• W2077080091 hasConcept C126322002 @default.
• W2077080091 hasConcept C126894567 @default.
• W2077080091 hasConcept C134018914 @default.
• W2077080091 hasConcept C27016395 @default.
• W2077080091 hasConcept C2777880890 @default.
• W2077080091 hasConcept C2779611605 @default.
• W2077080091 hasConcept C2779716603 @default.
• W2077080091 hasConcept C2779888176 @default.
• W2077080091 hasConcept C2779922275 @default.
• W2077080091 hasConcept C2781184683 @default.
• W2077080091 hasConcept C2781203188 @default.
• W2077080091 hasConcept C2908929049 @default.
• W2077080091 hasConcept C555293320 @default.
• W2077080091 hasConcept C71924100 @default.
• W2077080091 hasConcept C84393581 @default.
• W2077080091 hasConceptScore W2077080091C104849204 @default.
• W2077080091 hasConceptScore W2077080091C126322002 @default.
• W2077080091 hasConceptScore W2077080091C126894567 @default.
• W2077080091 hasConceptScore W2077080091C134018914 @default.
• W2077080091 hasConceptScore W2077080091C27016395 @default.
• W2077080091 hasConceptScore W2077080091C2777880890 @default.
• W2077080091 hasConceptScore W2077080091C2779611605 @default.
• W2077080091 hasConceptScore W2077080091C2779716603 @default.
• W2077080091 hasConceptScore W2077080091C2779888176 @default.
• W2077080091 hasConceptScore W2077080091C2779922275 @default.
• W2077080091 hasConceptScore W2077080091C2781184683 @default.
• W2077080091 hasConceptScore W2077080091C2781203188 @default.
• W2077080091 hasConceptScore W2077080091C2908929049 @default.
• W2077080091 hasConceptScore W2077080091C555293320 @default.
• W2077080091 hasConceptScore W2077080091C71924100 @default.
• W2077080091 hasConceptScore W2077080091C84393581 @default.
• W2077080091 hasIssue "2" @default.
• W2077080091 hasLocation W20770800911 @default.
• W2077080091 hasLocation W20770800912 @default.

• next